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Waste products of metabolism are retained in haemodialysis (HD) 
patients. Patients with greater energy expenditure generate more waste 
products and may require more dialysis. To determine the amount of dialysis 
required, equations estimating resting (REE) and total energy expenditure (TEE) 
are required. 
Methods 
We compared estimates of REE in HD patients using established 
equations with a novel equation recently validated in HD patients (HD equation). 
TEE was derived from REE (HD equation) and estimates of physical activity 
obtained by questionnaire. REE and TEE relationships with bioimpedance 
measured body composition were then determined.  
Results 
We studied 317 HD patients; 195 males (61.5%), 123 diabetic (38.9%), 
mean age 65.0±15.3 and weight 73.1±16.8 kg. REE from HD Equation was 
1509±241 kcal/day, which was greater than for Mifflin St Joer 1384±259, 
Harris-Benedict 1437±244, Katch-McArdle 1345±232 (all p<0.05 vs HD 
Equation), but less than Cunningham 1557±236 kcal/day. Bland Altman mean bias 
ranged from -263 to 55 kcal/day. TEE was 1727 (1558-1976) kcal/day, and on 
multi-variate analysis was positively associated with skeletal muscle mass (β 
23.3, p<0.001), employment (β 406, p<0.001), low co-morbidity (β 105, p=0.006), 
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and protein nitrogen appearance (β 2.7, p=0.015), and negatively with age (β -7.9, 
p<0.001), and dialysis vintage (β -121, p=0.002). 
Conclusions 
Most standard equations underestimate REE in HD patients compared to 
the HD Equation. TEE was greater in those with higher skeletal muscle mass and 
protein nitrogen appearance, lower co-morbidity, age, and dialysis vintage, and 
the employed. Such Patients are more metabolically active and may require 


















 Although haemodialysis is an established treatment for patients with 
chronic kidney disease (CKD), with around 3 million patients currently treated 
worldwide, 5-year mortality remains higher than that for some of the more 
common solid organ malignancies [1]. Dialysis treatments are currently designed 
to achieve an adequacy target in terms of solute clearance, using the 
dimensionless parameter Kt/Vurea, where K is dialyser urea clearance, t the 
dialysis session time and V the urea distribution volume (or Watson Volume [2]) 
equating to total body water.    Yet, when tested by a randomised prospective 
multicentre trial increasing dialyzer Kt/Vurea clearance failed to demonstrate 
greater patient survival [3], although, post-hoc analysis suggested that higher 
haemodialysis doses were associated with a survival advantage for women [4]. 
There are a number of possible explanations for this association, one of which 
may be the scaling of haemodialysis dose based on total body water [5].  
In CKD, the products of cellular metabolism accumulate and as such an 
alternative suggestion has been that the amount of dialysis a patient requires 
would depend upon their metabolic activity [6]. Metabolic activity comprises 
both resting metabolic rate and that secondary to physical activity. Resting 
energy expenditure (REE) is relatively greater in smaller animals compared to 
larger animals, and rescaling the dialysis dose by body surface area (BSA) has 
been reported to demonstrate an association between increasing Kturea/BSA 
and patient survival [7]. However, this approach fails to take in to account active 
energy expenditure. To be able to adjust the amount haemodialysis for an 
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individual patient then we need to develop simple methods of estimating total 
energy expenditure which are valid in patients with advanced CKD.  
Several equations have been developed for estimating REE [8-12], but 
these did not include patients with CKD. As such we have recently developed an 
equation to estimate REE in dialysis patients and, based on this,  a method to 
estimate total energy expenditure (TTE), which has been validated in doubly 
labelled water studies [13,14].  
We wished to compare the HD Equation in haemodialysis patients with 
other equations commonly used to estimate REE, which were developed from 
other patient populations. In addition, we wished to determine whether there 
was an association between REE and TEE and body composition as measured by 
bioelectrical impedance.  
 
Patients and methods 
  We recruited a total of 317 adult patients under the care of a university 
hospital attending for outpatient thrice weekly haemodialysis. Patient 
demographics were obtained from computerised hospital records and 
comorbidity determined using a self-administered co-morbidity grading, based 
on medical conditions and complications, including diabetes mellitus (as defined 
by WHO criteria), cardiac disease, respiratory disease, liver disease, arthritis, 
depression and malignancy [15].  
We compared estimates of REE using the HD Equation [13,14], with those 
calculated using the modified Harris-Benedict equation [8,9], the Mifflin St. 
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Joer [10], Katch McArdle [11] and Cunningham equations [12]. Physical activity 
data was obtained through the validated Recent Physical Activity Questionnaire 
(RPAQ) [16]. The RPAQ collects information about activities performed at home, 
work and leisure time and also the time spent on each activity in the preceding 4 
weeks [13]. Physical activity data was determined by each reported activity 
being assigned a Metabolic Equivalent of Task (MET) value according to the 
Compendium of Physical Activities [16]. This was then combined with REE 
estimated using the HD equation to provide an estimate of TEE (see appendix) 
Measurements of body composition were made using multi-frequency 
bioelectrical impedance assessments (MFBIA) (InBody 720, InBody, Seoul, 
South Korea). Bioimpedance measurements are routinely collected as part of 
determining HD patient target weight. Patients with pacemakers, and other 
implantable cardiac devices, and those unable to stand to measure bioimpedance 
were excluded from study. Measurements were performed in a standardised 
manner, post the mid-week haemodialysis session, after allowing for post-
dialysis recovery [17,18]. Previous studies have validated this device against dual 
electron X ray absorptiometry [19]. Lean body mass index (LBMI) and fat mass 
index (FMI) were calculated by lean body mass (LBM) and fat mass (FM) divided 
by height squared, respectively. Skeletal muscle mass (SMM) was derived from 
measurement of limb muscle mass (appendicular muscle mass). Body surface area 
was calculated using the Gehan and George equation as recommended by the 
European Best Clinical Practice guidelines [20].  
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The Cunningham and Katch McArdle equations use an estimate of lean 
body mass [11,12], with lean body mass estimated by subtracting percentage 
body fat from patient weight. We calculated REE using both percentage body 
fat and also lean body mass measured by MFBIA.  
Patients dialysed using Fresenius 4008H (Fresenius Bad Homberg, 
Germany) or Dialogue R+ (BBraun, Melsungen, Germany) with high flux 
polysulfone dialyzers (Elisio, Nipro Corporation, Osaka, Japan) [21] and 
anticoagulated with single bolus low molecular weight heparin (Tinzaparin, Leo 
Laboratories, Hurley, Berkshire, UK) [22]. Haemoglobin and serum urea, 
creatinine and electrolytes were measured by standard laboratory analyzers 
(Sysmex XE5000, Sysmex Corporation, Kobe, Japan and Roche Cobra, Roche 
Instruments Ltd, Basingstoke, UK), and serum β2 microglobulin was measured by 
rate nephelometry (www.Dako.com, Image 800 analyser, Beckman Coulter, High 
Wycombe, UK) [23]. 
 Dialysis machines were regularly serviced and dialysate conductivity 
checked [24,25]. Haemodialysis adequacy was calculated as an equilibrated 
Kt/Vurea, and protein  nitrogen appearance from pre- and post-dialysis 
measurements [26] and the inter-dialytic interval and bioimpedance total body 
water. Interdialytic urine collections were not available.  
Ethical approval for determining energy expenditure was granted by the 
UK National Research Ethics Committee – North Wales and the study was 
registered in UK Clinical Research Network (CRN) Portfolio number 12023. All 
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 Statistical analysis was by t test, Man Whitney U test, paired t test and 
Wilcoxon rank sum pair test, ANOVA or Kruskal-Wallis analysis, with 
appropriate post hoc correction for multiple testing, Pearson or Spearman’s 
correlation (GraphPad Prism version 6.0, San Diego, USA), and Bland Altman 
comparison (Analyse-It version 3.0, Leeds, UK). Variables associated with REE 
and TEE, p<0.1 and those thought to be clinically relevant were entered into a 
multivariable analysis and then eliminated in a step back manner if variables 
were not significant, unless they improved model fit (SPSS 22.0, SPSS 
University Chicago, USA). Multivariable models were checked for collinearity. 
Data are presented as mean ± standard deviation, median (inter quartile range), 
or mean and 95% limits of agreement (CI), or as a percentage. 
 
Results 
We studied 317 adult haemodialysis patients; 195 males (61.5%), 123 
diabetic (38.9%), mean age 65.0±15.3 years, with a median dialysis vintage 3.3 
(1.4-6.2) years. 138 (43.5%) were Caucasoid, 101 (31.9%) African/Afro-
Caribbean, 65 (20.5%), South Asian, 9 (2.8%) East Asian, and the remainder of 
indeterminate ethnicity. The mean weight was 73.1±16.8 kg with a body mass 
index of 26.2±5.8 kg/m2, with a median co-morbidity grade of 2 (0-4). 41 
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patients (13%) were in employment. The mean equilibrated dialysis sessional 
Kt/Vurea was 1.40 ±0.27, with a mean dialysis session time of 236 ±26 minutes, 
median ultrafiltration volume 1.8 (1.0-2.2) L, and daily protein nitrogen 
appearance rate based solely on change in serum urea during the inter-dialytic 
interval, 42.1 (30.8-53.5) g/day. Pre-dialysis haemoglobin was 110.5±11.9 g/L, 
serum albumin 40.3±4.2 g/L, cholesterol 3.9 ±1.1 mmol/L, C reactive protein 
(CRP) 4.0 (2-9) mg/L, urea 18.0±5.2 mmol/L, serum creatinine 710 (572-863) 
umol/L, cholesterol 4.0 ±1.0 and glucose 7.1 ±2.6 mmol/L, serum β2 microglobulin 
28.6 ±9.4 mg/L and post-dialysis serum urea 4.6 ±1.8 mmol/L. The median weekly 
erythropoietin dosage was 5000 (2000-8000) Iu/week. 
The mean REE using the HD Equation was 1532±237 kcal/day, with a TEE 
of 1727 (1558 – 1976) kcal/day. The REE determined by the HD Equation was 
significantly greater than that for the modified Harris-Benedict, Mifflin St. 
Joer equations, and the Katch McArdle equation using lean body mass (Figure 1). 
REE was also calculated by estimating lean body mass from percentage body fat 
using the Katch McArdle and Cunningham equations, which over estimated REE 
compared to other equations (table 1).  
Resting and total energy expenditure was less for female patients, who 
had less muscle mass, but greater body fat (table 1). Bland Altman plots showed 
that the majority of REE equations under estimated REE compared to the HD 
Equation, however using percentage body fat to estimate lean body mass, led to 
an over estimation of REE (Figure 2). 
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A number of demographic and dialysis associated variables and body 
composition measurements were associated with both REE and TEE (table 2). 
REE was greater in African-Afro-Caribbean patients compared to white or south 
Asians (1563±245 vs 1492±246 and 1434±210 kcal/day respectively), p<0.05, but 
TEE did not differ between ethnic groups. Patients in employment had greater 
REE (1613±247 vs 1493±237 kcal/day, p<0.01) and TEE (2268±453 vs 1731±307 
kcal/day, p<0.001). There was no difference in REE or TEE between those with 
low and high co-morbidity (REE 1507±233 vs 1515±262 and TEE 1813±383 vs 
1769±352 kcal/day). 
Multivariable models showed that REE was independently associated with 
skeletal muscle mass, and negatively with age and duration of treatment with 
haemodialysis. TEE was also associated with skeletal muscle mass, and negatively 
with age and duration of treatment with haemodialysis, but was also associated 
with employment status, low co-morbidity and inter-dialytic protein nitrogen 
appearance rate determined by the increase in serum urea (table 3). 
 
Discussion 
The kidney plays a key role in the excretion of the waste products of 
cellular metabolism. As serum urea has the highest serum concentration of any 
of these retention products of cell metabolism, then dialyzer urea clearance has 
been used to assess dialysis adequacy. However prospective clinical studies 
designed to investigate the effects of increasing dialyzer urea clearance 
targets failed to demonstrate any survival advantage [3]. Re-analysis of this 
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data, and other reports have suggested that the delivered amount of dialysis 
was affected by body size and gender [4,5,27]. Body size and gender are key 
determinants of energy expenditure [8], and it has been suggested that the 
amount of dialysis clearance required by patients should be adjusted for 
metabolic rate [6].  
A number of equations estimating REE have been proposed over the last 
hundred years or so, which have been based on studies from various populations, 
generally including healthy subjects of varying body mass index and ages [8-12]. 
However body composition can be affected by CKD, particularly in terms of 
muscle wasting [28,29], as well as the potential effects of co-morbidities such 
as diabetes [30]. More recently an REE equation based on studies of UK patients 
on haemodialysis has been developed [13,14,31]. To determine how this CKD REE 
equation compared with standard equations estimating REE we studied a cohort 
of HD outpatients. We used multi-frequency bioelectrical impedance to measure 
body composition [32]. Although this is an accepted technique, bioimpedance 
measurements are affected by volume status, so we used bioimpedance 
measurements taken post-dialysis when patients were closest to their target 
weight, to minimise the effect of over hydration [33]. 
We found that the mean bias for both the modified Harris-Benedict 
tgvo/jsgv brcdeswx[8,9] and Mifflin St.Joer [10] equations under estimated 
REE compared to the HD Equation, for both male and female HD patients. Both 
the Katch McArdle [11] and Cunningham [12] equations can be calculated either 
by using directly estimated lean body mass or lean body mass obtained by 
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subtracting percentage body fat from body weight. We used both methods 
entering lean body mass and percentage body fat measured by bioimpedance. 
Using lean body mass, mean bias for the Katch-McArdle equation under 
estimated REE, whilst the Cunningham equation over estimated REE. In contrast 
using percentage body fat both over estimated REE compared to the HD 
Equation.  
Although the mean bias between the HD and the Harris-Benedict 
equation was modest at 73 kcal/day, the 95% limits of agreement of this and 
the other equations were very large for both genders. REE depends upon the 
metabolic activity of high energy internal organs; including the brain, liver, 
kidneys, and heart [34].  Increased REE in HD patients compared to healthy 
subjects would be supported by previous reports of impaired mitochondrial 
energy transfer and increased muscle breakdown in patients with kidney failure 
[28,29], and the effect of the dialysis treatment itself. 
Using percentage body fat, REE calculated from the Katch-McArdle and 
Cunningham equations was significantly greater compared to that using lean body 
mass.  Changes in body composition, in particular changes in muscle mass [27,28], 
alter the relationship between percentage body fat and muscle mass in CKD. 
Hence assumptions made based on body composition in healthy subjects may not 
hold for CKD patients.  
All REE equations use anthropomorphic measurements. We noted that in 
addition to patient age and gender, REE was associated with anthropomorphic 
measurements, but also with ethnicity which has been reported to alter body 
 13 
composition [35], dialysis session time, dialyzer surface area, pre-dialysis serum 
urea, creatinine, albumin and haemoglobin, and the inter-dialytic interval protein 
generation based on the increase in serum urea, along with body composition, and 
employment status. REE was inversely associated with haemodialysis vintage and 
dialysis dose (equilibrated Kt/V) on univariate analysis. Longer dialysis vintage 
could be associated with loss of residual renal function, although there was no 
association with β2 microglobulin concentrations. Previous studies have reported 
that the determination of dialysis dosing using Kt/V overestimates delivered 
dose in small patients and those with a lower pre-dialysis serum urea [4,5]. 
A multivariable model noted that REE derived by the HD Equation was 
independently associated with skeletal muscle mass, and negatively with both 
age and years of haemodialysis treatment. Both the Katch McArdle and 
Cunningham equations estimate REE based on lean body mass [11,12]. Muscle 
mass can influence energy and protein metabolism throughout the body, as 
muscle plays a key role in glucose uptake and storage, and is also a large 
potential reservoir of amino acids stored as protein, which can be released when 
supplies are needed elsewhere in the body [36]. Muscle mass declines with age 
[37], and previous reports have commented on reduced muscle glycogen stores in 
muscle biopsies from haemodialysis patients [38]. 
 We also calculated TEE, by including energy expenditure due to physical 
activity [16]. Compared to REE, on univariate analysis TEE was positively 
associated with haemoglobin, and negatively with erythropoietin dose, and 
erythropoietin resistance. Higher haemoglobins may improve performance in 
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endurance athletes, such as cyclists, whereas the negative association with 
erythropoietin dose could be due to a number of confounders including 
erythropoietin resistance associated with inflammation and muscle wasting [39]. 
On multivariable analysis, we found that TEE was also associated with protein 
nitrogen appearance assessed by the inter-dialysis increase in serum urea. This 
is in keeping with reports of energy intake being associated with skeletal muscle 
mass [40], and also with the relationship of TEE and urea generation rate [31]. 
In addition, TEE was associated with employment status and low co-morbidity. It 
would be expected that patients with greater co-morbidity would be less 
physically active as would those who were not in employment. 
If the amount of dialysis a patient requires is related to energy 
expenditure, then equations which are relatively simple to apply in routine 
clinical practice are required. Our study demonstrates that in this setting, 
estimates of REE obtained using an equation derived in HD patients are higher 
than those obtained using standard equations. Both REE and TEE were 
independently associated with skeletal muscle mass, and negatively with age and 
duration of treatment with haemodialysis.  Understanding the relationship 
between body composition and energy expenditure is important for patients with 
kidney failure treated by dialysis, as patients with greater TEE generate more 
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Figure 1: Resting energy expenditure (REE) measured using the HD Equation 
[7,8], with the modified Harris-Benedict equation [11,12], the Mifflin St. Joer 









Figure 2a: Bland Altman plots of resting energy expenditure (REE) kcal/day 
measured using the HD Equation compared with the modified Harris-Benedict 
equation (mean bias women -96 (95% limits of agreement -244 to 52), men -263 
(-855 to -329). 
 
Figure 2b: Bland Altman plots of resting energy expenditure (REE) kcal/day 
measured using the HD Equation compared with the Mifflin St. Joer equation 
(mean bias women -191 (-330 to -52), men -86 (-205 to 34). 
 
 
Figure 2c: Bland Altman plots of resting energy expenditure (REE) kcal/day 
measured using the HD Equation compared with the the Katch McArdle using 
lean body mass (mean bias women -214 (-550 to 121) mean bias men -160 (-560 
to 239)  
 
Figure 2d: Bland Altman plots of resting energy expenditure (REE) kcal/day 
measured using the HD Equation compared with the Cunningham equation using 
lean body mass; women mean bias -4.4 (-340 to 331), men 53 (-350 to 457)  
 
Figure 2e: Bland Altman plots of resting energy expenditure (REE) kcal/day 
measured using the HD Equation compared with Katch McArdle equation 
calculated from % body fat with a mean bias for women 357 (-124 to 840) mean 
bias men 299 (-270 to 869 
 
Figure 2f: Bland Altman plots of resting energy expenditure (REE) kcal/day 
measured using the HD Equation compared with Cunningham equation calculated 
from % body fat with a mean bias for women mean bias 577 (83 to 1072), men 







Resting Energy Expenditure (REE) was estimated from a newer novel predictive 
equation which was derived and validated in a cohort of HD patients [4].  
 
REE = -2.497 * Age(years) * Factorage + 0.011 * Height2.023(cm) + 83.573 * 
Weight0.6291(kg) + 68.171 * Factorsex 
 
where Factor age is 0 if age <65 and 1 if ≥65 and Factor sex is 0 if female and 1 
if male 
 
Physical activity data - Each reported activity was assigned a Metabolic 
Equivalent of Task (MET) value as per the Compendium of Physical Activities 
[16]. Sleep time per day was assumed to be 8 hours and any unreported time 
during the day was assumed as the time performing light activities at home. A 
Mean daily MET value was calculated. 
 
Total Energy Expenditure (TEE) was estimated from the following equation. 
  TEE = REE * Mean Daily MET 
.   
 
Table 1: Table comparing male and female patients, in terms of body composition 
and resting energy expenditure (REE) estimated by five different equations, 
using either lean body mass or weight minus % body fat for the Katch McArdle 
and Cunningham equations.  Data expressed as number, mean ± standard 
deviation, or percentage † p<0.05 vs REE HD equation  * p<0.05, ** p<0.01, 
p<0.001 vs male patients. 
 
  Patients Male  Female 
number 317 195 122 
Age years 65.0±15.9 66.9 ±15.2 63.4 ±15.5 
Body mass index kg/m2 26.2±5.8 25.8 ±4.6 27.0 ±7.3 
Pre dialysis serum urea mmol/L 18.0±5.2 18.3 ±5.1 17.6 ± 5.3 
Equilibrated dialysis session 
Kt/Vurea 
1.40±0.27 1.36 ±0.26 1.46 ±0.28** 
% Body fat  31.6±11.8 29.0 ± 0.3 35.7 ±12.9*** 
Lean body mass kg 26.2±6.6 28.3 ±6.4 22.8 ±5.4*** 
Appendicular muscle mass kg 19.1±6.3 20.7 ±6.3 16.1 ±4.6*** 
Fat mass index kg/m2  23.4±12.3 21.9 ±10.4 26.4 ±14.8* 
Fat free mass index kg/m2 17.4±2.7 17.9 ±2.6 16.4 ±2.6*** 
REE HD Equation kcal/day  1509±241 1572 ±215 1408 ±248*** 
REE Harris-Benedict kcal/day 1437±244† 1515 ±233  1311 ±206*** 
REE Mifflin StJoer kcal/day 1384±259† 1417 ±229 1218 ±240*** 
REE Katch McArdle kcal/day 1345±232† 1571 ±227 1206 ±188*** 
REE Cunningham kcal/day 1557±236 1631 ±224 1416 ±192*** 
REE Katch McArdle (%body fat) 1834±239 1873 ±387 1770 ±417** 
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kcal/day 
REE Cunningham (%body fat) 
kcal/day 
2055±391 2095 ±364 1990 ±425** 
















Statistically significant univariate associations between resting energy 
expenditure (REE) and total energy expenditure (TEE) and patient 
demographics, dialysis factors and body composition. (r values) as Pearson or 
Spearman.  
 
variable REE  TEE  
demographics r p r p 
Age yr -0.455 <0.001 -0.521 <0.001 
months of haemodialysis -0.236 <0.001 -0.201 0.003 
Dialysis associated factors     
session time hour 0.498 <0.001 0.318 <0.001 
dialyzer surface area m2 0.469 <0.001 0.409 <0.001 
Protein nitrogen appearance  
generation g/day 
0.428 <0.001 0.405 <0.001 
equilibrated Kt/V -0.419 <0.001 -0.456 <0.001 
Pre dialysis blood results     
creatinine umol/L 0.375 <0.001 0.395 <0.001 
urea mmol/L 0.212 <0.001 0.249 <0.001 
haemoglobin g/L 0.099 0.079 0.149 0.008 
albumin g/L 0.146 0.011 0.221 0.001 
weekly erythropoietin dose IU -0.077 0.168 -0.120 0.031 
erythropoietin resistance 
IU/week.kg.gHb 
-0.258 <0.001 -0.268 <0.001 
Body size and composition     
Weight kg 0.886 <0.001 0.743 <0.001 
 22 
extracellular water L 0.719 <0.001 0.561 <0.001 
intracellular water L 0.681 <0.001 0.643 <0.001 
skeletal muscle mass kg 0.717 <0.001 0.640 <0.001 
skeletal muscle mass index kg/m2 0.665 <0.001 0.643 <0.001 
fat free mass  kg 0.658 <0.001 0.279 <0.001 
height m 0.619 <0.001 0.578 <0.001 
body mass index kg/m2 0.521 <0.001 0.378 <0.001 
fat free mass index kg/m2 0.481 <0.001 0.477 <0.001 
body fat mass kg 0.461 <0.001 0.290 <0.001 
fat mass index kg/m2 0.419 <0.001 0.272 <0.001 










Multivariable association with resting energy expenditure (REE) and total energy 
expenditure (kcal/day). Age years, Skeletal muscle mass (SMM) kg, log dialysis 
vintage (vintage) years, co-morbidity score Low vs High (Comorbidity), 
employment vs no employment (employment), protein nitrogen appearance (PNA) 
g/day. Standard error β (StE β), standardised β (St β), 95% confidence interval 
(95% CI). (REE model: r2  0.79, adjusted r2 0.62, TEE model:  r2 =0.81, adjusted 
r2 0.64).  
 
 β StE β St β t 95% CI p 
REE       
age -5.3 -0.69 -0.32 -7.6 -6.7 to -3.9 <0.001 
SMM 14.9 1.02 0.62 14.7 13.0 to 16.9 <0.001 
vintage -96.7 22.9 -0.17 -4.2 -141.9 to -51.5 <0.001 
TEE       
age -7.9 1.25 -0.29 -6.3 -10.4 to -5.5 <0.001 
SMM 23.3 2.87 0.40 8.1 17.5 to 28.9 <0.001 
employment 406.5 49.7 0.37 8.2 308 to 505 <0.001 
vintage -121.2 38.1 -0.14 -3.2 -196 to -46 0.002 
Co-morbidity 105.1 3.82 0.12 -2.8 30.5 to 181 0.006 
PNA 2.7 1.09 0.12 2.5 0.5 to 4.8 0.015 
  
 
